Detailed Analysis of Insulin Absorption Variability and the Tissue Response to Continuous Subcutaneous Insulin Infusion Catheter Implantation in Swine
Overview
Pharmacology
Authors
Affiliations
Background: Worldwide, ∼1 million people manage their type 1 diabetes with an insulin pump and a continuous subcutaneous insulin infusion (CSII) catheter. Patients routinely insert a new catheter every 2-3 days due to increasing variability of insulin absorption over time. Catheter insertion and maintenance damage capillaries, lymphatics, cells, and connective tissue leading to an acute inflammatory response.
Methods: We compared an investigational CSII catheter (IC) and a commercial CSII catheter (CC) regarding insulin absorption pharmacokinetics (PK) and tissue inflammation. The two different catheter designs were implanted into the subcutaneous tissue of six swine for 5 days. Insulin boluses were given on days 1, 3, and 5 of wear-time to assess PK. Tissue around catheters was excised and stained to visualize inflammation and morphological changes of adjacent tissue.
Results: Insulin absorption was better when infused through a CC with highest C and fastest t values on day 5 of catheter wear-time. Both catheter types produced high intra- and intersubject day-to-day insulin absorption variability. The IC caused significantly more tissue disruption and lead to irregular changes in tissue morphology. Both catheter types were surrounded by a layer of inflammatory tissue that varied in composition, thickness, and density over time. A catheter that was manually inserted by pushing a sharp tip through the skin caused more trauma and variability than a 90° Teflon cannula with automated insertion.
Conclusions: Insulin absorption variability could be attributed to the layer of inflammatory tissue, which may function as a mechanical barrier to insulin flow into adjacent vascular tissue. The impact of the acute inflammatory tissue response on insulin absorption has to be considered in future catheter designs. A catheter that was manually inserted by pushing a sharp tip through the skin caused more trauma and variability than a 90° Teflon cannula with automated insertion.
Degen I, Robson Brown K, Reeve H, Abdallah Z JMIRx Med. 2024; 5:e44384.
PMID: 39654139 PMC: 11612581. DOI: 10.2196/44384.
Zhang Y, Kuo L, Woodhouse K, Fitzpatrick L ACS Pharmacol Transl Sci. 2024; 7(8):2544-2556.
PMID: 39156741 PMC: 11325997. DOI: 10.1021/acsptsci.4c00363.
Jacquemier P, Retory Y, Virbel-Fleischman C, Schmidt A, Ostertag A, Cohen-Solal M Sci Rep. 2023; 13(1):20052.
PMID: 37973963 PMC: 10654403. DOI: 10.1038/s41598-023-46993-1.
Closed loop insulin delivery-Opportunities and limitations.
Weiss R J Diabetes. 2023; 15(12):1103-1106.
PMID: 37855262 PMC: 10755602. DOI: 10.1111/1753-0407.13490.
McKiel L, Ballantyne L, Negri G, Woodhouse K, Fitzpatrick L Front Immunol. 2023; 14:1232586.
PMID: 37691934 PMC: 10491479. DOI: 10.3389/fimmu.2023.1232586.